cTRL Therapeutics Appoints Derrell D. Porter, M.D., as Chief Executive Officer

Biopharma industry veteran to lead company's development of solid tumor cell therapies engineered with immune cells from blood instead of surgically removed cancer tissue SAN FRANCISCO, Nov. 1, 2023 -- (Healthcare Sales & Marketing Network) -- cTRL The... Biopharmaceuticals, Oncology, Personnel cTRL Therapeutics, circulating tumor-reactive lymphocytes
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news